Evidence map›Paper›PMID 34803710›Full record

ArticleFrontiers in pharmacology2021

Focused Proteomics Analysis of Habu Snake (

Tomohisa Ogawa, Yu Tobishima, Shizuka Kamata, Youhei Matsuda, Koji Muramoto, Masafumi Hidaka, Eugene Futai, Takeshi Kuraishi, Shinichi Yokota, Motonori Ohno and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Tomohisa OgawaLaboratory of Enzymology, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.
Yu TobishimaGraduate School of Life Sciences, Tohoku University, Sendai, Japan.
Shizuka KamataGraduate School of Life Sciences, Tohoku University, Sendai, Japan.
Youhei MatsudaGraduate School of Life Sciences, Tohoku University, Sendai, Japan.
Koji MuramotoGraduate School of Life Sciences, Tohoku University, Sendai, Japan.
Masafumi HidakaLaboratory of Enzymology, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.
Eugene FutaiLaboratory of Enzymology, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.
Takeshi KuraishiInstitute of Medical Science, University of Tokyo, Kagoshima, Japan.
Shinichi YokotaInstitute of Medical Science, University of Tokyo, Kagoshima, Japan.
Motonori OhnoDepartment of Applied Life Science, Faculty of Bioscience and Biotechnology, Sojo University, Kumamoto, Japan.
Shosaku HattoriInstitute of Medical Science, University of Tokyo, Kagoshima, Japan.
Tohoku University · JPInternational University of Kagoshima · JPSojo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snakebites are one of the major causes of death and long-term disability in the developing countries due to the presence of various bioactive peptides and proteins in snake venom. In Japan, the venom of the habu snake (

Indexed as

antivenommyonecrosisphospholipase A2proteomicspseudoenzymeserine proteasesnake venomvenomics

Identifiers

PMID34803710
PMCPMC8599580
OpenAlexW3213660807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.